This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2014) (Learn how and when to remove this template message) This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (June 2014) (Learn how and when to remove this template message) (Learn how and when to remove this template message)
Rohto Pharmaceutical Co., Ltd.
Native name
ロート製薬株式会社
Rōto Seiyaku kabushiki gaisha
Company typePublic KK
TYO: 4527
Industry
FoundedHigashinari-ku, Osaka, Japan (September 15, 1949 (1949-09-15), to reorganize "Shintendo, Yasutami Yamada pharmaceutical Company")
FounderYasutami Yamada
HeadquartersIkuno-ku, Osaka, Japan
Key people
  • Kunio Yamada (chair and CEO, great-grandson of the founder)
  • Toshiaki Yoshino (president and COO)
Revenue
  • Increase¥120,292 million (FY 2011)[* 1]
  • ¥115,472 million (FY 2010)
  • Increase¥13,624 million (FY 2011)[* 1]
  • ¥13,105 million (FY 2010)
  • Increase¥8,184 million (FY 2011)[* 1]
  • ¥7,966 million (FY 2010)
Total assets
  • Increase¥136,008 million (FY 2011)[* 1]
  • ¥126,472 million (FY 2010)
Total equity
  • Increase¥83,627 million (FY 2011)[* 1]
  • ¥77,911 million (FY 2010)
Number of employees
5,518 (March 31, 2013)
SubsidiariesMentholatum
Rohto Advanced Research Hong Kong Ltd
Websitewww.rohto.co.jp/global/
Footnotes / references
  1. ^ a b c d e "Financial Results for the Fiscal Year Ended March 31, 2012" (PDF). Rohto Pharmaceutical Co., Ltd. May 11, 2012. Retrieved November 12, 2012.

Rohto Pharmaceutical Co., Ltd. (ロート製薬株式会社, Rōto Seiyaku Kabushiki-gaisha) is a multinational fast-moving consumer goods and pharmaceutical corporation headquartered in Ikuno-ku, Osaka, Japan, with a presence in North America, Europe and Asia. The company is listed on the stock exchange, having posted steady increases in revenues from ¥95,619 million in 2006 to ¥120,292 million in 2011. Skin Care contributes to 61.3% of the revenues, while Eye Care contributes to 21% of their sales.

Market Segments

Rohto is active in the three consumer segments of:

International presence

In 1974, Rohto set its eyes on The Mentholatum Company. In August 1975, it acquired the trademark rights to Mentholatum and began to sell the Mentholatum Ointment and Mentholatum Medicated Lip Stick, which proved to be a financial success as the company's revenue skyrocketed to ¥2.64 billion by April 1981. Rohto Pharmaceutical Co. continued to acquire the management rights to The Mentholatum Company Inc in June 1988, thus completing the merge.

Rohto group has established operations in 15 major markets, with marketing/distribution agreements in more than 150 countries globally. They have two production plants in Japan and 6 production plants across US, UK, China, Vietnam, Hong Kong and Indonesia.

Rohto entered the Vietnam market in 1997 and set up their manufacturing base to cater to the Asia Pacific market. In mid-2010, Rohto entered the India and Bangladesh market.

The company has close to 5,000 employees.

Yasutami Yamada (山田 安民, Yamada Yasutami) founded "Shintendo, Yasutami Yamada Pharmaceutical Company (信天堂山田安民薬房)", the predecessor of Rohto, in Shimizucho, Higashi-ku (present: Shinsaibashi, Chuo-ku), Osaka on February 22, 1899. Yamada sold "Rohto Eyedrops" in 1909. "Rohto" was named after August von Rothmund,[note 1] a German ophthalmologist who was a professor for Toyotaro Inoue (井上 豊太郎, Inoue Toyotarō), a Japanese ophthalmologist.

Brands

Head Office and Subsidiaries

Notes

  1. ^ In Japanese, August von Rothmund was known as アウグスト・フォン・ロートムント (Augusuto-fon-Rōtomunto).